Inactive Instrument

Misonix, Inc.

Equities

MSON

US6048711039

Medical Equipment, Supplies & Distribution

Misonix, Inc. Reports Earnings Results for the First Quarter Ended September 30, 2020

November 06, 2020 at 03:16 am IST

Misonix, Inc. announced earnings results for the first quarter ended September 30, 2020. For the first quarter, the company announced sales was USD 17.735 million compared to USD 11.145 million a year ago. Operating loss was USD 4.047 million compared to USD 2.270 million a year ago. Net loss was USD 4.978 million compared to net income of USD 1.796 million a year ago. Basic loss per share from continuing operations was USD 0.29 compared to basic earnings per share from continuing operations of USD 0.18 a year ago. Diluted loss per share from continuing operations was USD 0.29 compared to diluted earnings per share from continuing operations of USD 0.17 a year ago.

Latest news about Misonix, Inc.

Misonix, Inc. Reports Earnings Results for the First Quarter Ended September 30, 2021	26/22/26	CI
Misonix, Inc.(NasdaqGM:MSON) dropped from S&P TMI Index	01/21/01	CI
Misonix, Inc.(NasdaqGM:MSON) dropped from S&P Global BMI Index	01/21/01	CI
Misonix, Inc.(NasdaqGM:MON) dropped from NASDAQ Composite Index	29/21/29	CI
Bioventus Inc. completed the acquisition of Misonix, Inc. from Stavros G. Vizirgianakis, SV Life Sciences Fund VI, L.P. and Sv Life Sciences Fund VI Strategic Partners, L.P., funds managed by SV Health Investors, LLC, 1315 Capital, LLC and others.	29/21/29	CI
Misonix : Q4 Net Loss Narrows, Revenue Surges	03/21/03	MT
Misonix : Earnings Flash (MSON) MISONIX Posts Q4 Revenue $19.7M	03/21/03	MT
Misonix, Inc. Reports Earnings Results for the Fourth Quarter Ended June 30, 2021	03/21/03	CI
Misonix, Inc. Announces Nonrenewal of Allan Staley as President and Named Executive Officer	13/21/13	CI
MISONIX : BTIG Downgrades Misonix to Neutral From Buy	02/21/02	MT
Misonix : Bioventus to Acquire Misonix in Cash-and-Stock Deal Valued at $518 Million	31/21/31	MT
NASDAQ 100 : Top Midday Gainers	30/21/30	MT
MISONIX : Craig-Hallum Downgrades Misonix to Hold From Buy; Price Target is $28	30/21/30	MT
MISONIX : Canaccord Genuity Downgrades Misonix to Hold From Buy; Price Target is $28	30/21/30	MT
Transcript : Bioventus Inc., Misonix, Inc. - M&A Call	30/21/30
Misonix, Inc. Reported Revenue Results for the Fiscal Fourth Quarter and Full Year 2021	30/21/30	CI
Bioventus Inc. entered into a definitive agreement to acquire Misonix, Inc. from Stavros G. Vizirgianakis, SV Life Sciences Fund VI, L.P. and Sv Life Sciences Fund VI Strategic Partners, L.P., funds managed by SV Health Investors, LLC, 1315 Capital, LLC and others for approximately $500 million.	29/21/29	CI
Transcript : Misonix, Inc. Presents at UBS Global Healthcare Virtual Conference 2021, May-25-2021 05:00 PM	26/21/26
Misonix, Inc. Announces Board Changes	14/21/14	CI
Transcript : Misonix, Inc., Q3 2021 Earnings Call, May 06, 2021	07/21/07
Misonix : Earnings Flash (MSON) MISONIX Reports Q3 Revenue $18.3M, vs. Street Est of $18M	07/21/07	MT
Misonix, Inc. Reports Earnings Results for the Third Quarter Ended March 31, 2021	06/21/06	CI
Misonix, Inc. Provides Earnings Guidance for the Year of 2021	06/21/06	CI
Misonix : Files Shelf for Up to $100 Million in Securities	23/21/23	MT
Misonix : Receives Regulatory Approval to Sell neXus in Canada; Shares Rise Early	04/21/04	MT

Chart Misonix, Inc.

Duration

Period

More charts

Company Profile

Misonix, Inc. (Misonix), is a medical devices company. The Company is engaged in designing, manufacturing and marketing of minimally invasive therapeutic ultrasonic medical devices. Its products include BoneScalpel Surgical System (BoneScalpel), SonicOne Wound Cleansing and Debridement System (SonicOne) and SonaStar Surgical Aspirator (SonaStar). BoneScalpel is used for surgical procedures involving the precise cutting and sculpting of bone while sparing soft tissue. SonaStar is used to emulsify and remove soft and hard tumors, primarily in the neuro and general surgery field. SonicOne offers tissue specific debridement and cleansing of wounds and burns for effective removal of devitalized tissue and fibrin deposits while sparing viable cells. The Company's products are nexus, BoneScalpel, SonaStar, SonicOne, TheraSkin and Therion.

Sector

Medical Equipment, Supplies & Distribution

More about the company

Sector Medical Equipment

	1st Jan change	Capi.
SHOCKWAVE MEDICAL, INC.	+73.70%	12.4B
PENUMBRA, INC.	-17.02%	7.94B
MASIMO CORPORATION	-1.68%	6.17B
JIANGSU YUYUE MEDICAL EQUIPMENT & SUPPLY CO., LTD.	+16.74%	5.55B
GETINGE AB	-3.21%	5.35B
APT MEDICAL INC.	+46.20%	5.03B
ASAHI INTECC CO., LTD.	-17.59%	4.07B
INARI MEDICAL, INC.	-29.91%	2.65B
SKAN GROUP AG	-0.74%	1.99B

Medical Equipment